DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Gainor JF, Tan DS, De Pas T et al.
Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib.
Clin Cancer Res 2015;
21: 2745-2752
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.